ASCLEPIOS SPOLKA AKCYJNA secures contract for Pharmaceutical products Successive deliveries of cytostatic drugs and drug programs

Poland, April 16 -- Poland based ASCLEPIOS SPOLKA AKCYJNA has secured contract from Krajowa Izba Odwolawcza for Pharmaceutical products Successive deliveries of cytostatic drugs and drug programs. The value of the contract is worth 14738170 PLN.

Published by HT Digital Content Services with permission from Pivotal Sources....